Paris, France

Mathilde Latil

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Creteil, FR (2016)
  • Saint Maur des Fosses, FR (2018)
  • Paris, FR (2023)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mathilde Latil: Innovator in Neuromuscular and Eye Disease Treatments

Introduction

Mathilde Latil is a prominent inventor based in Paris, France. She has made significant contributions to the fields of neuromuscular diseases and eye treatments. With a total of 5 patents, her work focuses on innovative solutions for complex medical conditions.

Latest Patents

Latil's latest patents include groundbreaking research on phytoecdysones and their derivatives for treating neuromuscular diseases. This patent discloses the use of 20-hydroxyecdysone and its derivatives specifically for conditions like spinal muscular atrophy and amyotrophic lateral sclerosis. Another notable patent involves chemical compounds targeting the eye, particularly derivatives of norbixin. These compounds are intended for the treatment of eye diseases, including age-related macular degeneration and Stargardt's disease.

Career Highlights

Throughout her career, Mathilde Latil has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Biophytis. Her research has been pivotal in advancing treatments for debilitating conditions, showcasing her dedication to improving patient outcomes.

Collaborations

Latil has collaborated with notable colleagues, including René Lafont and Pierre Dilda. These partnerships have further enriched her research and innovation efforts.

Conclusion

Mathilde Latil stands out as a key figure in the development of treatments for neuromuscular and eye diseases. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…